-+ 0.00%
-+ 0.00%
-+ 0.00%

Harmony Biosciences appoints Glenn Reicin as CFO

PUBT·04/14/2026 12:09:22
Listen to the news
Harmony Biosciences appoints Glenn Reicin as CFO
  • Harmony Biosciences appointed Glenn Reicin as chief financial officer, effective immediately.
  • Reicin most recently served as CFO at Eccogene, leading buildout of financial infrastructure to prepare for an IPO.
  • He previously served as CFO and chief operating officer at Alladapt Immunotherapeutics, overseeing fundraising and operational buildout.
  • Harmony reiterated 2026 net product revenue guidance of $1.0 billion to $1.04 billion.
  • Sandip Kapadia is departing the CFO role.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Harmony Biosciences Holdings Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260414988782) on April 14, 2026, and is solely responsible for the information contained therein.